Literature DB >> 27133491

Patient-Reported Outcome Measures in Systemic Sclerosis (Scleroderma).

Russell E Pellar1, Theresa M Tingey1, Janet Elizabeth Pope2.   

Abstract

Scleroderma (systemic sclerosis) is a rare autoimmune connective tissue disease that can damage multiple organs and reduce quality of life. Patient-reported outcome measures capture the patient's perspective. Some measures are specific to systemic sclerosis and others are general. Patient-reported outcomes in systemic sclerosis are important to aid in understanding the impact of systemic sclerosis on patients.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Health-related quality of life; Patient-reported outcome measures; Patient-reported outcomes; Scleroderma; Systemic sclerosis

Mesh:

Year:  2016        PMID: 27133491     DOI: 10.1016/j.rdc.2016.01.003

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  3 in total

1.  Can Routine Use of Patient-Reported Outcomes Help Guide Systemic Sclerosis Chronic Disease Care?

Authors:  Tracy M Frech; Rachel Hess; Joshua Biber; Jeffrey Young; Alexander Hardman; Howard Weeks; Kathryn A Peterson; Mary Beth Scholand
Journal:  J Clin Rheumatol       Date:  2018-08       Impact factor: 3.517

2.  Factors associated with early postoperative survey completion in orthopaedic surgery patients.

Authors:  Patrick Mj Sajak; Ali Aneizi; Rohan Gopinath; Vidushan Nadarajah; Cameran Burt; Dominic Ventimiglia; Ngozi Akabudike; Min Zhan; R Frank Henn
Journal:  J Clin Orthop Trauma       Date:  2019-07-19

Review 3.  Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019.

Authors:  Kevin L Winthrop; Michael E Weinblatt; Joan Bathon; Gerd R Burmester; Philip J Mease; Leslie Crofford; Vivian Bykerk; Maxime Dougados; James Todd Rosenbaum; Xavier Mariette; Joachim Sieper; Fritz Melchers; Bruce N Cronstein; Ferry C Breedveld; Joachim Kalden; Josef S Smolen; Daniel Furst
Journal:  Ann Rheum Dis       Date:  2019-10-29       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.